摘要
目的了解多药耐受菌在临床上的分布,对控制与预防多药耐受菌感染的干预对策进行效果评价,指导临床有效诊断与控制多药耐受菌的感染情况。方法统计我院2013年多药耐受菌临床分布状况,在综合干预1年后,再对2015年多药耐受菌临床分布状况进行检测统计,比较两者之间的差异。结果在2013年的4 357株菌株中共有603株多药耐受菌被检出,检出率为13.8%,其中革兰氏阴性菌最多,有421株,占69.8%,检出最多的科室是ICU,占30.2%。在综合干预后,多药耐受菌的检出率下降至11.6%。结论应及时掌握多药耐受菌的临床状况,了解其变化趋势,并且采取综合干预的手段,对多药耐受菌感染率的降低具有明显的意义。
Objective To investigate the distribution of multidrug resistance bacteria in clinic, evaluate the effect of intervention measures on the prevention and control of infection of multi drug resistant bacteria infection, guide the clinical diagnosis and effective control of multi drug resistant bacteria. Methods Statistical data of our hospital in 2013 the clinical distribution of multi drug resistant bacteria, in 1 years after the comprehensive intervention, and then in 2015 the multi drug resistant bacteria to detect the clinical distribution of statistics, compare the difference between the two. Results In 2013 of 4 357 strains of the Chinese communist party has 603 strains of multi drug resistant bacteria were detected, the detection rate of 13.8%, which was the largest gram negative bacteria, there were 421 strains, accounting for 69.8%, the most detected in the Department was ICU, accounting for 30.2%. In the comprehensive intervention, the detection rate of multi drug resistant bacteria decreased to 11.6%. Conclusion The clinical status of multi drug resistant bacteria should be mastered in a timely manner, to understand the change trend, and to take the means of comprehensive intervention, to reduce the infection rate of multi drug resistant bacteria has obvious significance.
出处
《中国继续医学教育》
2016年第31期31-32,共2页
China Continuing Medical Education
关键词
多药耐受菌
临床分布
干预
Multi drug resistant bacteria
Clinical distribution
Intervention